OKLAHOMA CITY -- For most, July 2020 may be an unremarkable space on the calendar. But for those in any way connected with pediatric hematology-oncology – the practice, the patients and families, providers - the date is significant, marking the end of an era.
OU Medicine, OU Health Sciences Center and Oklahoma Blood Institute are collaborating to determine the prevalence of Oklahoma healthcare workers who have previously been infected with the COVID-19 virus.
SCC participated in clinical trial proving effectiveness of an oral medication in key treatment advance.
Michael Cookson, M.D., chair of urology at the University of Oklahoma College of Medicine and Tyler Gunter, M.D., OU Medicine radiation oncologist, will discuss treatment options available at Stephenson Cancer Center.